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Rapid Activation of Transforming Growth Factor b–Activated
Kinase 1 in Chondrocytes by Phosphorylation and K63-Linked
Polyubiquitination Upon Injury to Animal Articular Cartilage
Heba M. Ismail,1 Athanasios Didangelos,2 Tonia L. Vincent,1 and Jeremy Saklatvala1
Objective. Mechanical injury to cartilage predis-
poses to osteoarthritis (OA). Wounding of the articular
cartilage surface causes rapid activation of MAP kinases
and NF-kB, mimicking the response to inflammatory cyto-
kines. This study was undertaken to identify the upstream
signaling mechanisms involved.
Methods. Cartilage was injured by dissecting it
from the articular surface of porcine metacarpophalangeal
(MCP) joints or by avulsing murine proximal femoral
epiphyses. Protein phosphorylation was assayed by West-
ern blotting of cartilage lysates. Immunolocalization of
phosphorylated activating transcription factor 2 (ATF-2)
and NF-kB/p65 was detected by confocal microscopy.
Messenger RNA (mRNA) was measured by quantitative
reverse transcriptase–polymerase chain reaction (qRT-
PCR). Receptor associated protein 80 (RAP-80) ubiquitin
interacting motif agarose was used in a pull-down assay to
obtainK63-polyubiquitinated proteins. Ubiquitin linkages on
immunoprecipitated transforming growth factorb–activated
kinase 1 (TAK-1) were analyzedwith deubiquitinases.
Results. Sharp injury to porcine cartilage caused
rapid activation of JNK and NF-kB pathways and the
upstream kinases MKK-4, IKK, and TAK-1. Pharmaco-
logic inhibition of TAK-1 in porcine cartilage abolished
JNK and NF-kB activation and reduced the injury-
dependent inflammatory gene response. High molecular
weight species of phosphorylated TAK-1 were induced by
injury, indicating its ubiquitination. An overall increase in
K63-linked polyubiquitination was detected upon injury,
and TAK-1 was specifically linked to K63- but not K48-
polyubiquitin chains. In mice, avulsion of wild-type femo-
ral epiphyses caused similar intracellular signaling that
was reduced in cartilage-specific TAK-1–null mice. Epi-
physeal cartilage of MyD88-null and TRAF-6–null mice
responded to injury, suggesting the involvement of a ubi-
quitin E3 ligase other than TRAF-6.
Conclusion. Activation of TAK-1 by phosphoryla-
tion and K63-linked polyubiquitination by injury indicates
its role in driving cell activation. Further studies are
needed to identify the upstream ubiquitination mecha-
nisms, including the E3 ligase involved.
Traumatic injury to vascular tissues causes inflam-
mation and wound healing, but how tissues sense mechan-
ical injury is not understood. A prevailing view is that
sterile inflammation is promoted by damage causing
release of intracellular materials such as ATP, S100A pro-
teins, heat-shock proteins, and high mobility group box
chromosomal protein 1, the latter acting via Toll-like
receptors (TLRs) to induce an inflammatory response
(1–6). In this view, normal constituents released from
damaged or stressed cells act as mediators analogously to
microbial pathogen–associated molecular patterns and
have been termed damage-associated molecular patterns
(DAMPs). The cellular players have not been character-
ized, but it would follow that macrophages would respond
to DAMPs and orchestrate inflammation.
We have studied the effects of mechanical injury
on articular cartilage because such injury predisposes to
osteoarthritis (OA). Simply cutting the articular cartilage
surface from porcine metacarpophalangeal (MCP) joints
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has been shown to cause rapid intracellular signaling with
activation of NF-kB,MAP kinases (7,8), protein kinase B,
and Src, followed by induction of inflammatory response
genes (9). The response resembled those elicited by bacte-
rial lipopolysaccharide (LPS) or inflammatory cytokines
such as interleukin-1 (IL-1) and tumor necrosis factor
(TNF), but we found no soluble mediator arising from the
injured tissue to explain it. An interesting feature was that
cutting the cartilage again in culture, having allowed the
first response to die down, did not induce the full range of
inflammatory signaling, but induced only activation of
ERK, due to release of pericellular fibroblast growth
factor (7,10,11). Thus, the tissue in vivo had an alarm that
was activated by injury but was not reset in culture. Fresh
tissue is therefore needed for experiments.
Synovium is a vascular connective tissue that has a
variety of cell types, but shows the same pattern of intra-
cellular signaling upon cutting injury (9), suggesting that
the response is generic. After working with porcine tissue,
we studied mice to see if their response was the same. It is
not possible to make discrete scalpel injuries to murine
articular cartilage in quantities sufficient for analysis.
Instead, we avulsed the proximal femoral epiphysis from
5-week-old animals. This injury shears through the carti-
laginous growth plate. The same pattern of activation of
MAP kinases, NF-kB, and inflammatory response genes
as was seen in porcine tissue occurred (12).
The role of inflammation in OA is uncertain, but
since mechanical injury predisposes to OA and directly
activates inflammatory signaling, it seemed important to
understand the molecular mechanism of the response.
Further evidence of the relevance of inflammatory signal-
ing is that the MAPK/JNK pathway controls aggrecan
degradation by chondrocytes (13), and in OA induced by
destabilizing the knee, JNK-2–null mice showed reduced
aggrecan degradation and slower disease progression (14).
The inflammatory triggers whose mechanisms are
best understood are LPS, IL-1, and TNF. These signal via
their receptors through transforming growth factor b–
activated kinase 1 (TAK-1) (15,16). TAK-1 is bound to
TAB-1 (17–19), which binds to K63-linked polyubiquitin
chains whose formation is triggered by activation of the
receptors. Binding of the TAK-1/TAB-1 complex to K63-
polyubiquitin chains facilitates TAK-1 autophosphorylation
and activation (20,21). The g subunit of the IKK complex
also binds to K63-polyubiquitin. TAK-1 then activates the
IKKs andMAP kinase kinases.
In LPS and IL-1 signaling, theK63-polyubiquitination
is carried out by TNF receptor–associated factor 6 (TRAF-
6), a ubiquitin E3 ligase, working in conjunction with the E2
complex Ubc13/Uev1A, and E1 (22,23). TLR-4 (the LPS
receptor) and IL-1 receptor (IL-1R) are homologous and
when liganded interact with the adaptor protein myeloid dif-
ferentiation factor 88 (MyD88). IL-1R–associated kinases
bind to these receptor complexes and activate TRAF-6. The
K63-polyubiquitin chains formed may be free or attached to
proteins, including TRAF-6 itself, IRAK, and TAK-1 (24).
TNF receptor type I also signals via TAK-1 but uses TRAF-2
and TRAF-5 as E3 ligases (25). K63-polyubiquitination cau-
ses proximity-induced signaling (26) in contrast to K48-poly-
ubiquitination, which targets proteins for degradation (27).
In this study, we have shown that mechanical injury
to cartilage activates NF-kB and MAP kinases via TAK-1,
that there is formation of K63-polyubiquitin chains, and
TAK-1 is a target. The polyubiquitination pattern after
injury is distinct from that caused by either IL-1 or TNF,
and TRAF-6 is not involved. Thus, chondrocytes respond
directly to local mechanical injury of cartilage with signaling
and gene expression characteristic of inflammation, which is
driven by an unidentified ubiquitin E3 ligase and could
cause cartilage destruction inOA.
MATERIALS AND METHODS
Reagents and antibodies. Anti–TAK-1 (catalog no.
D94D7), anti–MKK-4 (catalog no. 9152S), anti–phospho–
MKK-4T261 (catalog no. 9151S), anti-IkB (catalog no. 4814S),
anti–phospho-IkB, Ser32/36 (catalog no. 9246), anti–phospho–
p38-T180/Y182 (catalog no. 9211S), anti–phospho–TAK-1-T184/
187 (catalog no. 45085), anti–phospho–IKKa/b-Ser176/180 (cata-
log no. 16A6), and anti–phospho–activating transcription factor 2
(ATF-2)–Thr71 (catalog no. 9221) were from Cell Signaling Tech-
nology. Anti–phospho–JNK-pTpY183/185 (catalog no. 44682G)
was obtained from Invitrogen. Anti–T-ERK (catalog no. sc-94),
anti–NF-kB–p65 (catalog no. Sc-372), anti–TAK-1 (catalog no. sc-
7162), and anti–phospho–TAK-1-S192 (catalog no. sc-130219)
were from Santa Cruz Biotechnology. Anti-ubiquitin–Lys-63–
specific antibody (catalog no. 05-1308) was from Millipore. Myelin
basic protein (MBP; catalog no. M1891) and anti–phospho-ERK
(catalog no. M9692) were from Sigma. A ubiquitin chain restric-
tion enzyme analysis (UbiCREST) kit (catalog no. K-400) was
obtained from R&D Systems, and g32P-ATP was obtained from
PerkinElmer. TAK-1 inhibitor 5z-7-oxozeanol (catalog no. 3604)
was from Tocris.
Cartilage injury and culture. Porcine cartilage.Artic-
ular cartilage was obtained from the MCP joints of the forefeet
of freshly slaughtered 3–6-month-old pigs purchased from a
local abattoir. Forefeet were first decontaminated in 2% Virkon,
then equilibrated at 378C. MCP joints were opened and injury
to cartilage was induced by rapidly dissecting it from the articu-
lar surface and cutting it into small pieces (1–2 mm3) as previ-
ously described (9). Cartilage was either snap-frozen (at time
point 0) or cultured for various amounts of time in serum-free
medium. In some experiments, joints were first injected with 5 mM
TAK-1 inhibitor (2 ml/joint) or DMSO in Dulbecco’s modified
Eagle’s medium and then equilibrated at 378C for 1 hour before
dissection.
Murine femoral epiphysis. Mice (5–6 weeks old) were
culled by cervical dislocation. Injury to the cartilaginous epiphy-
sis was induced after section of the acetabulofemoral ligament
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by avulsing the epiphysis with forceps as previously described
(12). The epiphyseal cartilage was either snap-frozen or cul-
tured for various amounts of time in serum-free medium.
Porcine and murine cartilage samples were then lysed
in 13 radioimmunoprecipitation assay (RIPA) buffer for
Western blotting or used for RNA extraction and inflammatory
gene expression analysis as previously described (9).
TAK-1 immunoprecipitation. ProteinGmagnetic beads
(Invitrogen) were washed with 13 RIPA buffer. TAK-1 was then
immunoprecipitated from cartilage lysates using TAK-1–specific
antibody (1:250) overnight at 48C in the presence of 50 ml/ml pro-
tein G magnetic beads, with rotation. Beads were then centrifuged
and washed with 13 RIPA buffer, and immunoprecipitates were
analyzed by Western blotting or kinase activity was assessed by
UbiCREST assay.
TAK-1 kinase assay. TAK-1 was immunoprecipitated
from cartilage lysates as described above (;0.5 gm cartilage per
time point). Beads were washed 3 times in 13 RIPA buffer and
washed once in 50 mM Tris HCl (pH 7.5). Beads were then resus-
pended in 25 ml of freshly prepared kinase buffer (50 mM Tris
HCl [pH 7.5], 100 mM EGTA, 100 mg/ml bovine serum albumin,
10 mM MgCl2, 100 mM Na3VO4, 2 mM EDTA, 1 mM micro-
cystin, and10 mM ATP) supplemented with 2 mg of MBP as sub-
strate and 5 mCi g32P-ATP. Reactions were carried out at 308C
for 30 minutes and then terminated by adding 15 ml of 53
sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-
PAGE) sample buffer and boiling for 5 minutes. Samples were
then analyzed by SDS-PAGE, and the amount of 32P incorpo-
rated into MBP was assessed by autoradiography and quantified
by phosphorimaging (Fujifilm FLA-5100 phosphorimager).
Pull-down assay for polyubiquitinated proteins using
receptor associated protein 80 (RAP-80) ubiquitin interacting
motifs (UIMs). UIMs in RAP-80 preferentially bind K63-linked
ubiquitin. RAP-80–UIM resin was equilibrated by washing with
13 RIPA buffer. Fifty microliters of washed resin was incubated
with 1 ml of cartilage lysates overnight at 48C with rotation. RAP-
80 resin was then centrifuged at 2,800 revolutions perminute for 3
minutes at 48C and washed 3 times with 13 RIPA buffer. Beads
were resuspended in 13 sample buffer, and the bound proteins
were analyzed by Western blotting using anti–K63 ubiquitin-
specific antibody.
Ubiquitin chain restriction enzyme analysis. A Ubi-
CREST kit was used to identify the type of ubiquitin linkages
bound to TAK-1, according to the recommendations of the man-
ufacturer. Briefly, TAK-1 was immunoprecipitated from cartilage
lysates as described above. Cartilage lysates from 3 joints were
used for each set of assays. Immunocomplexes were then washed
3 times with RIPA buffer and 1 time with deubiquitinase dilution
buffer. Beads were then divided into 9 equal parts. In 50 ml
deubiquitinase buffer aliquots, 5 ml of a deubiquitinase was
added to each tube and incubated for 30 minutes at 378C. Tubes
were then centrifuged, and supernatants were used for primary
analysis by SDS-PAGE and silver staining of released ubiquitin
chains, while the beads were analyzed for the efficiency of deubi-
quitinase enzyme cleavages by Western blotting. The deubi-
quitinase enzymes have the following linkage specificity: OTUD3
cleaves K6- and K11-linked polyubiquitin; CEZANNE cleaves K11-
linked polyubiquitin only; His6-TARBID cleaves K29-, K33-, and
K63-linked polyubiquitin; otubain 1 (OTUB-1) cleaves K48-linked
polyubiquitin only; GST-AMSH cleaves K63-linked polyubiquitin
only; YOD1 cleaves K6-, K11-, K27-, K29-, and K33-linked
polyubiquitin; OTULIN cleaves linear polyubiquitin only; and
USP2 cleavesmost ubiquitin linkages (used as a positive control).
NF-kB and phospho–ATF-2 immunofluoresence stain-
ing. Full-thickness porcine cartilage explants were snap-frozen
in liquid nitrogen immediately after completion of the experi-
ment (immediately after injury for time point 0 and immediately
after incubation for the 30-minute time point). Explants were
then cryosectioned using a cryostat (CM-1900; Leicia Micro-
systems) operated at 2208C. Cartilage sections were air dried at
room temperature for 1 hour, fixed with 4% paraformaldehyde
in 13 phosphate buffered serum (PBS) for 20 minutes, and then
washed briefly with 13 PBS. Cells were permeabilized with 0.2%
Triton X-100 in 13 PBS for 20 minutes. Sections were blocked
in 10% goat serum for 1 hour and then incubated with primary
antibodies (1:100) overnight at 48C. Following incubation, sec-
tions were washed with 13 PBS, incubated with Alexa Fluor
488–conjugated secondary antibodies for 2 hours and 2 mg/ml
propidium iodide, and then washed and mounted in 50% glyc-
erol in 13 PBS. Signals were visualized by Ultraview confocal
microscopy (Nikon Eclipse TE2000U).
Animals. C57BL/6 (wild-type) mice were purchased
from Charles River. MyD88-null and TAK-1 (MAP3K7) loxP-
flanked (floxed) mice were originally acquired from The Jackson
Laboratory. The CreER aggrecan promoter line (28) was gener-
ated at the Kennedy Institute by George Bou-Gharios. Animal
experiments were performed after ethics and statutory approval
was obtained in accordance with local policy. Mice were main-
tained at 218C in standard, individually ventilated cages holding
4–6 mice per cage.
TRAF-6–null animals were generated at the Institute of
Medical Science, University of Tokyo, and distributed from
RIKEN BioResource Center. In TRAF-6–knockout mice, a 2.5-
kb genomic fragment was replaced with a neomycin selection cas-
sette. Heterozygous animals were used for breeding. Homozygous
TRAF-6–mutant mice have been reported to exhibit severe osteo-
petrosis and abnormal immune cell development and function,
and die within ;2 weeks after birth (29). In our experiments,
homozygous offspring were very sick with breathing difficulties. In
some instances there were no homozygous offspring.
TAK1fl/fl; AggCreERT2 cartilage-specific–knockout mice
were generated by crossing floxed TAK-1 mice (TAK1fl/fl,
B6;129S7-Map3k7tm1Mds/J) with AggCreERT2 mice. All mice
were on a C57BL/6J background, and their genotype was deter-
mined by polymerase chain reaction (PCR). Mutation of TAK-1
and incorporation of aggrecan Cre was confirmed by PCR using
the following primer sets: for TAK-1, forward 50-AGCTCGC-
TGGTAGTGGTGTT-30 and reverse 50-GCCCCACTGTGAA-
TCTGAAA-30; for AggCre, forward 50-GCATTACCGGTCGA-
TGCAACGAGTGATGAG and reverse 50-GAGTGAACGAA-
CCTGGTCGAAATCAGTGCG.
All mice (floxed, controls, and crossed lines) were
injected intraperitoneally with tamoxifen (50 mg/kg) for 3 con-
secutive days at age 4–5 weeks. Two weeks after the last injec-
tion, mice were used in injury experiments. Loss of TAK-1 was
confirmed by Western blotting.
RESULTS
Rapid activation of the NF-kB and JNK path-
ways and their upstream regulators in response to
cartilage injury. Dissection of porcine MCP joint carti-
lage from the articular surface induced rapid activation of
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the NF-kB pathway. Phosphorylation of IKK was seen
within 30 seconds and was maximal after 30 minutes. This
was associated with degradation of IkB. IkB was
resynthesized between 10 and 30 minutes, and the newly
synthesized protein was phosphorylated and degraded
(Figure 1A). Injury also rapidly activated the JNK path-
way (Figure 1B). MKK-4, a JNK activator, was phosphory-
lated by 1 minute, JNK itself by 2 minutes, and its
substrates ATF-2 (Figure 1B) and c-Jun (results not
shown) by 5 minutes. In addition, the 2 other MAP
kinases, p38 and ERK, were phosphorylated within 30
seconds of injury (Figure 1B).
To determine whether activation of NF-kB and JNK
is propagated through the tissue, the extent of translocation
of the p65 subunit of NF-kB from cytoplasm to nucleus (Fig-
ure 1C), and the presence of phosphorylated ATF-2 (Figure
1D), were analyzed by confocalmicroscopy of the deep,mid-
dle, and superficial zones of the cartilage ex vivo at time point
0 and 30 minutes after dissection and culture. The cut was
made through the deep zone, so chondrocytes at the cut sur-
face lie along the bottom of the deep zone panels shown in
Figures 1C and D. NF-kB p65 appears green in the cyto-
plasm and yellow in nuclei. Before injury, the majority of
p65 was cytoplasmic (Figure 1C). The percentage of cells
Figure 1. Activation of the NF-kB and JNK pathways and their upstream regulators in injured porcine cartilage. Porcine metacarpophalangeal
joints were equilibrated at 378C for 1 hour. Articular cartilage was dissected and either snap-frozen or kept in serum-free medium for the indicated
times. A and B, Cartilage was washed with 13 phosphate buffered saline and lysed in radioimmunoprecipitation assay buffer. Lysates were analyzed
by Western blotting for phospho-IKK (ph-IKK), phospho-IkB, and IkB (A) and for phospho-MKK-4, phospho-JNK, phospho–activating transcrip-
tion factor (phsopho–ATF-2), phospho-p38, and phospho-ERK (B). ERK was blotted to check that the lanes were equally loaded. Results are repre-
sentative of several replicate experiments. C and D, After incubation, cartilage was embedded in OCT, and cryosections were stained with antibodies
against the p65 subunit of NF-kB (C) or phospho-ATF-2 (D). The localization of the 2 proteins in different cartilage zones was determined using
confocal microscopy. In each cryosection, a total of 500 cells were counted (100 cells in the superficial and deep zones and 300 in the middle zone).
Percentages are the proportion of activated cells in the different zones. Representative images are shown. Original magnification3 60.
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in which more than half of the nuclear area was yellow
(an arbitrary measure of NF-kB activation) is also shown in
Figures 1C and D. After injury, increased nuclear translo-
cation of NF-kB p65 was seen throughout the deep and
middle zones (Figure 1C), with the percentage of positive
cells increasing 2 and 4 times, respectively. Phosphorylation
of ATF-2 (shown in yellow) was seen in nuclei and was
much more pronounced in the deep and middle zones
following injury, with the percentage of positive cells
increasing by 2.5 and 4 times, respectively (Figure 1D).
TAK-1 is activated upon cartilage injury and
inhibition of TAK-1 abolishes injury-dependent gene
expression. TAK-1 activates JNK and NF-kB in response
to inflammatory stimuli. To investigate the role of TAK-1 in
injury, we analyzed its phosphorylation at T187 in the activa-
tion loop in lysates of cartilage made after increasing times
Figure 2. Cartilage injury leads to activation of transforming growth factor b–activated kinase 1 (TAK-1), and inhibition of TAK-1 abolishes injury-
dependent inflammatory gene expression. A, Porcine metacarpophalangeal (MCP) joints were equilibrated at 378C for 1 hour. Articular cartilage was dis-
sected and either snap-frozen or kept in serum-free medium for the indicated times. Cartilage was then washed with 13 phosphate buffered saline and
lysed in radioimmunoprecipitation assay buffer. Lysates were analyzed by Western blotting (WB) for phospho–TAK-1 (ph-T187), phospho-JNK, and
ERK. B, A TAK-1 activity assay was carried out as described in Materials and Methods to confirm TAK-1 activation. IP5 immunoprecipitation; ph-
MBP5 phospho–myelin basic protein. C and D, Porcine MCP joints were injected with 5 mM TAK-1 inhibitor 5z-7-oxozeanol (OXO) or DMSO (vehicle
[V]), as described in Materials and Methods, and kept at 378C for 1 hour. Joints were then opened and cartilage was dissected and snap-frozen (time point
0 minutes) or cultured for the indicated times with or without TAK-1 inhibitor. Cartilage lysates were analyzed for phospho-JNK and total ERK (T-ERK)
(C) and for IkB and total ERK (D). E, Cartilage was snap-frozen (time point 0 hours) or kept at 378C for 4 hours with or without 5 mM TAK-1 inhibitor
(OXO). RNA was extracted from the tissue and used in quantitative reverse transcriptase–polymerase chain reaction studies of a panel of typical inflam-
matory response genes. Bars show the mean6 SEM of 3 independent experiments. *5P, 0.05; **5P, 0.01, by unpaired t-test. NS5not significant; COX-
25 cyclooxygenase 2; IL-65 interleukin-6;MMP-35matrixmetalloproteinase 3; iNOS5 inducible nitric oxide synthase; TNF5 tumor necrosis factor. Color fig-
ure can be viewed in the online issue, which is available at http://onlinelibrary.wiley.com/journal/doi/10.1002/art.39965/abstract.
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following dissection. Western blotting showed that TAK-1
was phosphorylated by 2 minutes after injury (Figure 2A).
TAK-1 activation was confirmed by radiolabeled kinase
activity assay. For that assay, TAK-1 was immunoprecipita-
ted from lysates and assayed on MBP substrate. Incorpora-
tion of 32P from radiolabeled ATP was measured by
autoradiography. Phosphorylation of MBP was induced by
TAK-1 from lysates made 5 and 10 minutes after injury
(Figure 2B), confirming activation.
Next, we used a TAK-1 inhibitor, 5z-7-oxozeanol
(30), to see if inhibiting TAK-1 affected injury-dependent
activation of JNK and NF-kB and downstream gene induc-
tion. Porcine MCP joints were injected with TAK-1 inhibi-
tor or vehicle and kept at 378C for 1 hour. The joints were
then opened and cartilage was dissected and immediately
snap-frozen (time point 0), or kept in medium for various
amounts of time, with or without 5z-7-oxozeanol. The TAK-
1 inhibitor abolished JNK phosphorylation (Figure 2C) and
IkB degradation (Figure 2D) following injury. It also
reduced induction of mRNAs for injury-inducible genes
(Figure 2E).
Detection of higher molecular weight species of
phosphorylated TAK-1 in injured cartilage. On West-
ern blotting of lysates for phosphorylation of TAK-1 T187,
higher molecular weight phosphorylated species of ;180
kd and 250 kd were seen in addition to the ;80 kd form
(Figure 3A). An antibody recognizing both T187 and T184
phosphorylation showed amore complex pattern suggestive
of laddering, with the ;180 kd species being most pro-
nounced (Figure 3A). Phosphorylation of TAK-1 at S192,
which is also needed for maximal activation, was examined.
The ;80 kd band was induced by injury, but the ;180 kd
form was the major species, while the largest species was
not clearly discerned (Figure 3A). These complex patterns
suggested additional posttranslational modifications of
TAK-1, such as ubiquitination.
There was some increase in TAK-1 protein levels
(Figure 3A), possibly due to increased stability of TAK-1
protein following injury.
Overall increase in K63-linked polyubiquitination
in articular cartilage upon injury. To investigate the
involvement of ubiquitination, lysates were made from
injured porcine MCP cartilage, and K63-polyubiquitinated
proteins were obtained using a pull-down assay with beads
conjugated with RAP-80–UIM. Proteins pulled down with
RAP-80–UIM beads were analyzed by Western blotting
with antibodies to K63-linked ubiquitin. There was
increased K63-polyubiquitin chain formation within 5
minutes after injury (Figure 4A). A smeared pattern was
observed, suggesting that a number of proteins may be
ubiquitinated. The increase was also observed by immuno-
histochemistry with anti-K63 ubiquitin antibody in porcine
cartilage sections (Figure 4B). TAK-1 was detected in the
Rap-80 UIM pull-down assay (Supplementary Figure 1,
Figure 3. Higher molecular weight (Mwt) species of phosphorylated transforming growth factor b–activated kinase 1 (TAK-1) in injured porcine
and murine cartilage. A, Porcine metacarpophalangeal joints were processed as described in Figure 1. Cartilage was then dissected and either
snap-frozen (time point 0 minutes) or cultured for 5 or 10 minutes. Cartilage lysates were analyzed by Western blotting for TAK-1 phosphory-
lated at T187 (ph-T187), T184/T187, and S192, phospho-JNK, and total ERK (T-ERK; loading control). B, Murine proximal femoral epiphyses
(2 per time point) were subjected to avulsion injury, and were then either snap-frozen (time point 0 minutes) or cultured for 5 or 10 minutes in
serum-free medium. Epiphyses were analyzed by Western blotting for phospho–TAK-1, phospho-JNK, and total ERK (loading control) as
described in A. Representative results from 4 independent experiments are shown. NS5nonspecific.
570 ISMAIL ET AL
available on the Arthritis & Rheumatology web site at http://
onlinelibrary.wiley.com/doi/10.1002/art.39965/abstract).
TAK-1 from injured cartilage is linked to K63-
polyubiquitin but not to K48- or linear polyubiquitin
as in TNF- or IL-1–stimulated cartilage. Since there
was an overall increase in K63-polyubiquitination in
response to injury, we investigated whether TAK-1 is
K63-polyubiquitinated. TAK-1 was immunoprecipitated
from porcine cartilage lysates made at time point 0 or 10
minutes after dissection. Immunocomplexes were ana-
lyzed by Western blotting with anti-K63 ubiquitin anti-
body and then reprobing with anti–phospho-TAK-1
antibody. Injury to porcine MCP joint cartilage caused
K63-polyubiquitination and phosphorylation of TAK-1
in lysates made after injury (Figure 5A).
A UbiCREST kit was used to compare ubiquitin
chain linkages attached to the TAK-1 that was phos-
phorylated upon injury with those formed during IL-1
and TNF stimulation. The kit uses a panel of linkage-
specific deubiquitinases to analyze the linkages present
in polyubiquitin chains conjugated to a substrate pro-
tein (31). TAK-1 was immunoprecipitated from por-
cine cartilage lysates made 10 minutes after injury or
treatment with IL-1 or TNF. Following deubiquitinase
treatment, supernatants were analyzed by SDS-PAGE
and silver staining for the released ubiquitin (primary
analysis), and the beads were Western blotted with
anti-ubiquitin antibody for conjugated ubiquitin (sec-
ondary analysis).
A strong polyubiquitin signal was observed in
AMSH lanes (Figure 5B), indicating K63-poly-
ubiquitination of TAK-1. However, no detectable signal
was present in the OTUB-1 lane, indicating that injury
did not induce K48-polyubiquitination of TAK-1. Simi-
larly, OTULIN produced no detectable mono- or poly-
ubiquitin chains, demonstrating that TAK-1 was not
ubiquitinated by linear (Met1) linkages in response to
injury. Polyubiquitin chains were also detected in the
USP2-positive control lane. Comparing this pattern of
TAK-1 polyubiquitination with those induced by IL-1
and TNF (Figure 5B), we observed that the cytokines
induced a strong polyubiquitin signal in AMSH and
OTUB-1 lanes, indicating that TAK-1 is linked to K63-
and K48-polyubiquitin. OTULIN showed a positive sig-
nal of polyubiquitin chains only in the IL-1 set, indicat-
ing that IL-1 induced linear ubiquitination of TAK-1 by
a Met1-E3 ligase. These results suggest differences in
the polyubiquitin attached to TAK-1 in response to
injury, IL-1 stimulation, and TNF stimulation. Second-
ary analysis of samples treated with AMSH and OTUB-
1 by anti-ubiquitin Western blotting showed that the
ubiquitin chains attached to TAK-1 are mostly liberated
by AMSH, while OTUB-1 has no effect on the attached
ubiquitin chains (Figure 5C), confirming that injury
induced formation of K63- but not K48-polyubiquitin
chains on TAK-1.
Injury-induced signaling is reduced upon avul-
sion of femoral epiphysis in cartilage-specific TAK-1–
null mice but retained in TRAF-6–null and MyD88-null
mice. The injury-inducedK63-polyubiquitination of TAK-1
in porcine cartilage indicates activation of an E2–E3 ligase
complex. As previously described, TRAF-6 and TRAF-2
are the E3 ligases activated by IL-1 and TNF, respectively
(23), and TRAF-6 also mediates signaling by a number of
other stimuli. To explore further the upstream mechanisms
of injury-induced signaling, we investigated mice with avul-
sion injury of the proximal femoral epiphysis cartilage. This
Figure 4. Increased K63-linked polyubiquitin in injured porcine articular
cartilage. Porcine metacarpophalangeal (MCP) joints were equilibrated at
378C for 1 hour. A, Cartilage was dissected and either snap-frozen (time
point 0 minutes) or cultured for the indicated times. K63-linked ubiquitin
(UB-K63) proteins were obtained from cartilage lysates using a pull-down
assay with receptor associated protein 80 (RAP-80) ubiquitin interacting
motifs (UIMs) as described in Materials and Methods, and proteins
bound to the beads were analyzed by Western blotting (WB) with an
anti–K-63–linked ubiquitin antibody. Lysates were analyzed by Western
blotting for phospho-JNK (ph-JNK) and total ERK (T-ERK). Represen-
tative results from 3 independent experiments are shown. B, Porcine
MCP cartilage sections (5–7 mm) were deparaffinized, rehydrated, and
treated for 10 minutes with proteinase K for antigen retrieval. Endoge-
nous peroxidase activity was blocked with 3% H2O2 for 10 minutes, fol-
lowed by blocking with avidin–biotin for another 10 minutes. Sections
were then blocked for 2 hours at room temperature with 10% goat serum
in phosphate buffered saline, and incubated overnight at 48C with anti-
K63 ubiquitin antibody (1:50 dilution). Sections were washed and then
incubated for 2 hours in the dark with secondary antibodies conjugated
with streptavidin. Antibody binding was visualized using a Vectastain kit
and DAB Peroxidase Substrate Kit (Vector). Slides were then counter-
stained with hematoxylin and mounted with DPX. Original magnification
3 10. Color figure can be viewed in the online issue, which is available at
http://onlinelibrary.wiley.com/journal/doi/10.1002/art.39965/abstract.
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caused a pattern of TAK-1 phosphorylation and laddering
similar to that seen in porcine tissue (Figures 3A and B). To
confirm the importance of TAK-1, a mouse line expressing
CreER under control of an aggrecan promoter was crossed
with a TAK-1 floxed mouse line. Treatment of the progeny
with tamoxifen led to a cartilage-specific deletion of TAK-
1 (constitutive knockout of TAK-1 is fatal to the
embryo). Avulsion of femoral epiphyses from these ani-
mals showed that TAK-1 was needed for JNK activation
(Figure 6A). This corroborated the results of the experi-
ments with the inhibitor in porcine cartilage (Figure
2C). Western blotting of the mouse epiphyseal lysates
showed that avulsion also caused polyubiquitination
(Figure 6B).
Figure 5. Analysis of polyubiquitin chains linked to transforming growth factor b–activated kinase 1 (TAK-1) in injured cartilage compared to
that stimulated with interleukin-1 (IL-1) or tumor necrosis factor (TNF). Porcine metacarpophalangeal joints were processed and cartilage
lysates were prepared as described in Materials and Methods. A, TAK-1 was immunoprecipitated (IP) and analyzed by Western blotting (WB)
for K63-linked ubiquitin (UB-K63) or for TAK-1 phosphorylated at T187. B, TAK-1 was immunoprecipitated from injured cartilage, cartilage
stimulated with IL-1 for 10 minutes, and cartilage stimulated with TNF for 10 minutes. Immunocomplexes bound to beads were washed and
then divided into 9 tubes and used in ubiquitin chain restriction enzyme analysis as described in Materials and Methods. A different
deubiquitinase (DUB) was used in each tube as indicated. After incubation, supernatants were electrophoresed and gels were stained with silver
to detect released ubiquitin chains (primary analysis). Asterisks indicate the position of recombinant deubiquitinase enzymes. 1VE5 positive. C,
TAK-1 was immunoprecipitated from injured cartilage and then treated with AMSH or otubain 1 (OUTB-1) deubiquitinases as in B (primary
analysis). Supernatants were analyzed by silver staining, and beads were mixed with 13 sample buffer and analyzed by Western blotting with
anti-ubiquitin antibody (secondary analysis). Representative results from 3 independent experiments are shown. Color figure can be viewed in
the online issue, which is available at http://onlinelibrary.wiley.com/journal/doi/10.1002/art.39965/abstract.
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To investigate whether TRAF-6 is involved in injury-
dependent JNK activation, TRAF-6–null mice were gener-
ated (29). Homozygous null animals lived a maximum of
9–10 days and represented,10% of the offspring. Avulsion
experiments on TRAF-62/2, TRAF-62/1, and wild-type ani-
mals were performed on day 6. JNK was activated by injury
in all groups (Figure 6C), ruling out TRAF-6 as the major
injury-inducedE3 ligase.
MyD88 links signals from TLRs and IL-1R1 to
TRAF-6 and downstream signaling. To investigate its possi-
ble involvement in injury-dependent TAK-1 activation, we
tested MyD88-null mice. The absence of MyD88 had no
effect on TAK-1 activation or MAPK signaling caused by
avulsion (Figure 6D), indicating that Toll/IL-1 receptors do
not mediate the response, consistent with the findings of the
TRAF-6 experiments.
DISCUSSION
The speed with which injury to cartilage activated
signaling in chondrocytes in the present study was striking:
IKK, IkB, ERK, and p38 MAP kinase were phosphorylated
within 30 seconds. Phosphorylation of MKK-4 was detect-
able by 1 minute, JNK by 2 minutes, and ATF-2 by 5
minutes. Activation was propagated from the site of the cut
made in the deep zone of the porcine MCP cartilage up
Figure 6. Injury-induced signaling in avulsed murine epiphyses involves transforming growth factor b–activated kinase 1 (TAK-1) and is retained in
TRAF-6–null and MyD88-null mice. A, Cre recombination–mediated cartilage-specific TAK-1 deletion was induced by tamoxifen (TM; 50 mg/kg) as
described in Materials and Methods. Murine proximal femoral epiphyses (2 hips per time point) were avulsed and either snap-frozen (time point 0
minutes) or cultured for the indicated times in serum-free medium. Cartilage lysates were analyzed by Western blotting for TAK-1, phospho-JNK
(ph-JNK), and total ERK (T-ERK; loading control). B, Murine femoral epiphyses were avulsed, and lysates were analyzed by Western blotting for
ubiquitinated proteins and ERK. Ub-HRP5 horseradish peroxidase–conjugated ubiquitin. C, TRAF-6–null mice were generated as described in Mate-
rials and Methods. Top, DNA was extracted from the tips of the tails of 6-day-old animals for TRAF-6 genotyping polymerase chain reaction. Bottom,
Murine femoral epiphyses (1 hip per time point) were avulsed, and lysates were analyzed by Western blotting for phosphorylated JNK and total ERK
(loading control). D, Murine femoral epiphyses from MyD88-null mice were avulsed, and lysates were analyzed by Western blotting for phospho–
TAK-1, TAK-1, phospho-JNK, total ERK, phospho-p38, and phospho-ERK. HO5homozygous; HET5 heterozygous; WT5wild-type; KO5 knockout.
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into the mid-zone, a distance of ;20 chondrocyte lacunae
(the tissue is ;40 cells deep). Although we were unable to
identify any soluble factor released from damaged cartilage
to explain the effect, we cannot exclude the possible role of
a highly unstable factor. The signal could be propagated
between chondrocytes if there were connections between
them. Chondrocytes appear solitary in their lacunae, but
recent studies have shown long cytoplasmic extensions
crossing the extracellular matrix, possibly enabling commu-
nication through gap junction channels formed by connexin
43 (32,33). However, it is still not understood how the cells
sense the damage. The cell membrane is linked to the extra-
cellular matrix, and it is possible that connective tissue cells
directly detect changes in tension of the collagen fiber
network.
To elucidate the upstream mechanism of this
response, we investigated TAK-1, because it mediates cell
activation by several inflammatory stimuli. Injuring porcine
or murine cartilage activated TAK-1. TAK-1 inhibition
blocked NF-kB and JNK activation and injury-induced
gene expression. In mice, knocking out TAK-1 in cartilage
prevented JNK activation in response to epiphyseal avul-
sion. Taken together, these findings showed that TAK-1
plays an essential role inmediating the immediate response
to injury.
Injury caused phosphorylation of TAK-1 at T187
and S192 in both porcine and murine tissues, and it was
present in high molecular weight forms, suggesting its
ubiquitination. We found that K63-polyubiquitination
was occurring in the porcine cartilage upon injury and
that TAK-1 itself was K63-polyubiquitinated.
We used deubiquitinases to analyze the ubiquitin
chains on TAK-1. Injury induced K63- but not K48- or lin-
ear polyubiquitination, while stimulation by IL-1 or TNF
caused both K63- and K48-polyubiquitination. In addition,
IL-1 caused linear polyubiquitination. These distinct pat-
terns suggest that the injury-induced ubiquitin E3 ligase
may be distinct from TRAF-6 and TRAF-2, which are
induced by IL-1 and TNF, respectively. Further analysis is
required to detect the sites in TAK-1 ubiquitinated by
injury. K63-polyubiquitination occurs on TAK-1 at K158
and K562 in response to various stimuli including LPS, IL-
1, and TNF, and both sites are involved in the activation of
the kinase (22,23,34–37). However, TAK-1 can be acti-
vated by unanchored and linear polyubiquitin (38,39).
TAK-1 is activated by other injuries in other tis-
sues. It was phosphorylated in satellite cells upon skele-
tal muscle injury induced by barium chloride and
promoted myofiber regeneration (40). TAK-1 was also
activated in brain injury following experimental sub-
arachnoid hemorrhage or trauma, and its inhibition
reduced downstream signaling and neurologic deficits
(41,42).
Since TRAF-6 is the E3 ligase mediating a number
of stimuli, we investigated TRAF-6–knockout mice. Few
viable homozygous null offspring were obtained, but their
femoral epiphyses showed JNK activation upon avulsion.
Epiphyses from MyD88-knockout animals also responded
to injury, indicating that TLRs and IL-1R have no major
role in the response. These results, taken together with the
differences in TAK-1 ubiquitination caused by cytokines
and injury, suggest involvement of an E3 ligase other than
TRAF-6. Besides TRAF-2, E3 ligases known to generate
K63-polyubiquitin include tripartite motif–containing pro-
tein 25 (TRIM-25) (43), TRIM-8 (44), and mind bomb 2
(45). The E2-conjugating enzyme is also unknown.
Research on E2 and E3 enzymes involved in TAK-1 acti-
vation is limited, and proteomics analyses are needed to
detect the enzymes involved in the injury response.
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